Jounce Therapeutics to Present at Upcoming Investor Conferences in June
11 June 2019 - 10:00PM
Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company
focused on the discovery and development of novel cancer
immunotherapies and predictive biomarkers, today announced that
Jounce management will present at two upcoming investor
conferences:
- Raymond James Life Sciences and MedTech
Conference at 1:50 p.m. ET on Tuesday, June 18, 2019 in
New York, NY
- JMP Securities Life Sciences Conference at
11:00 a.m. ET on Wednesday, June 19, 2019 in New York, NY
A live webcast of each presentation will be available by
visiting “Events and Presentations” in the Investors and Media
section of Jounce’s website at www.jouncetx.com. A replay of each
webcast will be archived for 30 days following the
presentations.
About Jounce TherapeuticsJounce Therapeutics,
Inc. is a clinical-stage immunotherapy company dedicated to
transforming the treatment of cancer by developing therapies that
enable the immune system to attack tumors and provide long lasting
benefits to patients. Through the use of its Translational Science
Platform, Jounce first focuses on specific cell types within the
human tumor microenvironment to prioritize targets, and then
identifies related biomarkers designed to match the right
immunotherapy to the right patient. Jounce has three
development-stage programs: its two clinical product candidates,
vopratelimab, a monoclonal antibody that binds to and
activates ICOS, and JTX-4014, a monoclonal antibody that binds
to PD-1 and for potential use in combination with Jounce’s pipeline
of future product candidates, and JTX-8064, a monoclonal antibody
that binds to Leukocyte Immunoglobulin Like Receptor B2 (LILRB2)
that is currently in the IND-enabling phase. For more information,
please visit www.jouncetx.com.
Investor Contact:Komal JoshiJounce
Therapeutics, Inc.(857) 320-2523kjoshi@jouncetx.com
Media Contact:Gina NugentThe Yates Network(617)
460-3579gina@theyatesnetwork.com
Jounce Therapeutics (NASDAQ:JNCE)
Historical Stock Chart
From Apr 2024 to May 2024
Jounce Therapeutics (NASDAQ:JNCE)
Historical Stock Chart
From May 2023 to May 2024